T1	Participants 113 145	glottic squamous cell carcinomas
T2	Participants 389 411	T1-2 glottic carcinoma
T3	Participants 329 352	early glottic carcinoma
T4	Participants 453 456	282
T5	Participants 539 547	only 156
T6	Participants 568 624	82 patients were allocated to conventional fractionation
T7	Participants 700 732	74 patients to hypofractionation
T8	Participants 1196 1204	HYPO arm
T9	Participants 1416 1438	T1-2 glottic carcinoma
